Abstract
Aim:
To elucidate the effect and the mechanisms of curcumin on the expression of the human homeobox gene NKX3.1 in the prostate cancer cell LNCaP.
Methods:
The expression change of NKX3.1 in cells incubated with varying concentrations of curcumin was observed by Western blotting and RT-PCR. A dual luciferase reporter assay was used to test the effect of curcumin on the activity of the NKX3.1 1040 bp promoter. Curcumin-treated cells disposed to a designated amount of androgen analog R1881 and the androgen receptor (AR) antagonist flutamide, then the expression of NKX3.1 or the activity of the NKX3.1 promoter were investigated by Western blotting or reporter gene assay, respectively. Finally, Western blotting and electrophoretic mobility shift assay were performed to demonstrate the effect of curcumin on the expression of AR and its binding activity to the androgen response element (ARE).
Results:
Curcumin downregulated the expression of NKX3.1 and the activity of the NKX3.1 1040 bp promoter in LNCaP cells. R1881 increased the expression of NKX3.1, and the AR antagonist flutamide decreased the expression of NKX3.1 in LNCaP cells, while curcumin could inhibit androgen-AR mediated induction of NKX3.1 expression. Curcumin decreased the expression of AR and the binding activity to ARE directly.
Conclusion:
Curcumin could downregulate NKX3.1 expression in LNCaP cells. It could also inhibit the androgen-AR mediated induction of NKX3.1 expression by downregulating AR expression and blocking its DNA binding activity.
Similar content being viewed by others
Article PDF
References
Greenlee RT, Murray T, Bolden S, Wingo PA . The prostate: an increasing medical problem. Prostate 1990; 16: 39–48.
Hanks GE . Long-term control of prostate cancer with radiation. Urol Clin North Am 1996; 23: 605–16.
Garnick MB . Hormonal therapy in the management of prostate cancer: from Higgins to the present. Urology 1997; 49: 5–15.
Sommerkamp HW, Khauli RB . Role of dietary modification and vitamins in prostate cancer. J Med Liban 2005; 53: 103–6.
Li Y, Che M, Bhagat S, Ellis KL, Kucuk O, Doerge DR, et al. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia 2004; 6: 354–63.
Duvoix A, Morceau F, Delhalle S, Schmitz M, Schnekenburger M, Galteau MM, et al. Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol 2003; 66: 1475–83.
Shishu Singla, AK, Kaur IP . Inhibitory effect of curcumin and its natural analogues on genotoxicity of heterocyclic amines from cooked food. Indian J Exp Biol 2002; 40: 1365–72.
Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE . Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005; 11: 7490–8.
Choudhuri T, Pal S, Das T, Sa G . Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53 dependent manner. J Biol Chem 2005; 280: 20059–68.
Gautam SC, Xu YX, Janakiraman N, Chapman RA . Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant 2000; 25: 639–45.
Okazaki Y, Iqbal M, Okada S . Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 2005; 40: 357–66.
Gafner S, Lee SK, Cuendet M, Barthelemy S, Vergnes L, Labidalle S, et al. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 2004; 65: 2849–59.
Leu TH, Maa MC . The molecular mechanisms for the antitumorigenic effect of curcumin. Curr Med Chem Anticancer Agents 2002; 2: 357–70.
Dikshit P, Goswami A, Mishra A, Chatterjee M, Jana NR . Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function. Neurotox Res 2006; 9: 29–37.
Lee KW, Kim JH, Lee HJ, Surh YJ . Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 2005; 7: 1612–20.
Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH, Kim WK, et al. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun 2005; 335: 1017–25.
Cho JW, Park K, Kweon GR, Jang BC, Baek WK, Suh MH, et al. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 2005; 37: 186–92.
Dorai T, Gehani N, Katz A . Therapeutic potential of curcumin in human prostate cancer II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 2000; 4: 1–6.
Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE . Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. The Prostate 2001; 47: 293–303.
Bieberich CJ, Fujita K, He WW, Jay G . Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem 1996; 271: 31 779–82.
Jiang AL, Zhang PJ, Hu XY, Chen WW, Kong F, Liu ZF, et al. Identification of a positive Cis-element upstream of human NKX3.1 gene. Acta Biochim Biophys Sin 2005; 37: 773–8.
He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 1997; 43: 69–77.
Jiang AL, Hu XY, Zhang PJ, He ML, Kong F, Liu ZF, et al. Up-regulation of NKX3.1 expression and inhibition of LNCaP cell proliferation induced by an inhibitory element decoy. Acta Biochim Biophys Sin 2005; 37: 335–40.
Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12–21. Cancer Res 1996; 56: 2411–6.
Dong JT . Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001; 20: 173–93.
Voeller HJ, Augustus M, Madike V, Bova GS, Carter KC, Gelmann EP . Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res 1997; 57: 4455–9.
Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 2000; 60: 6111–5.
Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, et al. Roles for Nkx3.1 in prostate development and cancer. Genes Dev 1999; 13: 966–77.
Sadar MD, Hussain M, Bruchovsky N . Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer 1999; 6: 487–502.
Nakamura K, Yasunaga Y, Segawa T, Ko D, Moul JW, Srivastava S, et al. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 2002; 21: 825–30.
O'Malley B . The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol 1990; 4: 363–9.
Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA, et al. Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 1999; 69: 307–13.
Grossmann ME, Huang H, Tindall DJ . Androgen receptor signaling in androgen-refractory prostate cancer. J Nat Cancer Ins 2001; 93: 1687–97.
Culig Z . Androgen receptor cross-talk with cell signalling pathways. Growth Factors 2004; 22: 179–84.
Korkmaz KS, Korkmaz CG, Ragnhildstveit E, Kizildag S, Pretlow TG, Saatcioglu F . Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens. Gene 2000; 260: 25–36.
Prescott JL, Blok L, Tindall DJ . Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 1998; 35: 71–80.
Gao H, Ouyang X, Banach-Petrosky WA, Shen MM, Abate-Shen C . Emergence of androgen independence at early stages of prostate cancer progression in nkx3.1; pten mice. Cancer Res 2006; 66: 7929–33.
Abdulkadir SA . Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Ann N Y Acad Sci 2005; 1059: 33–40.
Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 2002; 62: 2999–3004.
Shen MM, Abate-Shen C . Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 2003; 228: 767–78.
Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 2003; 63: 3886–90.
Aslan G, Irer B, Tuna B, Yorukoglu K, Saatcioglu F, Celebi I . Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Pathol Res Pract 2006; 202: 93–8.
Xu LL, Srikantan V, Sesterhenn IA, Augustus M, Dean R, Moul JW, et al. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. J Urol 2000; 163: 972–9.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Project supported by grants from the National Natural Science Foundation of China (No 30470820) and the Natural Science Foundation of Shandong Province (NoY2004C26).
Rights and permissions
About this article
Cite this article
Zhang, Hn., Yu, Cx., Zhang, Pj. et al. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP. Acta Pharmacol Sin 28, 423–430 (2007). https://doi.org/10.1111/j.1745-7254.2007.00501.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00501.x
Keywords
This article is cited by
-
Natural compounds targeting nuclear receptors for effective cancer therapy
Cancer and Metastasis Reviews (2023)
-
Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells
Scientific Reports (2019)
-
A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study
Prostate Cancer and Prostatic Diseases (2014)
-
Effects of 14 single herbs on the induction of caspase-3 in tumor cells: A brief review
Chinese Journal of Integrative Medicine (2013)
-
Chemopreventive potential of curcumin in prostate cancer
Genes & Nutrition (2010)